Drug Profile

Ferric ferrocyanide - Heyl Chemisch-pharmazeutische Fabrik

Alternative Names: Insoluble Prussian blue; Radiogardase

Latest Information Update: 11 Apr 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Heyl Chemisch-pharmazeutische Fabrik
Developer Heyl Chemisch-pharmazeutische Fabrik; Nihon Medi-Physics
Class Ferric compounds; Small molecules
Mechanism of Action Binding agents

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Marketed Heavy metal poisoning

Most Recent Events

31 Mar 2025 Nihon Medi-Physics has been acquired by GE Healthcare
04 Feb 2019 Chemical structure information added

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com